GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) Net income
GE HealthCare Technologies Inc.'s net income for fiscal 2025 was $2.2B, up 5.07% from $2.1B in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.1B. Over the past ten years it has ranged from $1.6B (fiscal 2019) to $13.9B (fiscal 2020); the current reading is higher than 71% of that period. GE HealthCare Technologies Inc. ranks 5th of 149 Medical Devices companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $2.2B | 5.07% |
| FY2024 | $2.1B | 27.01% |
| FY2023 | $1.6B | (17.95%) |
| FY2022 | $2.0B | (14.22%) |
| FY2021 | $2.3B | (83.50%) |
| FY2020 | $13.9B | 794.85% |
| FY2019 | $1.6B | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $574.0M | 39.66% |
| Mar 2026 | $411.0M | (31.73%) |
| Dec 2025 | $602.0M | 29.74% |
| Sep 2025 | $464.0M | (7.20%) |
| 18 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| BSX Boston Scientific Corporation compare | $3.7B |
| GEHC GE HealthCare Technologies Inc. | $2.1B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| PHG Koninklijke Philips N.V. compare | $1.3B |
| EW Edwards Lifesciences Corporation compare | $1.0B |
| DXCM DexCom, Inc. compare | $999.7M |
| STE STERIS plc compare | $808.1M |
| ZBH Zimmer Biomet Holdings, Inc. compare | $807.0M |
| PEN Penumbra, Inc. compare | $160.6M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on GEHC
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement